Combine and conquer: handling biotech combination inventions in the wake of KSR.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 19430447.
- Also identified by DOI 10.1038/nbt0509-446.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To what extent will KSR limit combination inventions in biotech?
Medical subject headings
- Biotechnology
- Patents as Topic